MAGELLAN HEALTH INC (MGLN) Forecast, Price Target & Analyst Ratings

NASDAQ:MGLN

Current stock price

94.99
0 (0%)
At close:
94.99
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MAGELLAN HEALTH INC (MGLN).

Forecast Snapshot

Consensus Price Target

Price Target
$96.90
+ 2.01% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 4, 2022
Period
Q4 / 2021
EPS Estimate
$0.39
Revenue Estimate
1.293B
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$96.90
Upside
+ 2.01%
From current price of $94.99 to mean target of $96.90, Based on 6 analyst forecasts
Low
$95.95
Median
$96.90
High
$99.75

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for MGLN. The average price target is 96.9 null. This implies a price increase of 2.01% is expected in the next year compared to the current price of 94.99.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

MGLN Current Analyst RatingMGLN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

MGLN Historical Analyst RatingsMGLN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
MGLN was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about MGLN.
In the previous month the buy percentage consensus was at a similar level.
MGLN was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 4, 2022
Period
Q4 / 2021
EPS Estimate
$0.39
Revenue Estimate
1.293B
Revenue Q2Q
9.10%
EPS Q2Q
202.00%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

MGLN is expected to report earnings on 3/4/2022. The consensus EPS estimate for the next earnings is 0.39 null and the consensus revenue estimate is 1.29B null.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2021 - 2025

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
MGLN revenue by date.MGLN revenue by date.
4.958B
-15.09%		4.566B
-7.91%		4.578B
0.26%		5.002B
9.28%		5.401B
7.96%		5.881B
8.90%		6.252B
6.31%		6.78B
8.43%
EBITDA
YoY % growth
MGLN ebitda by date.MGLN ebitda by date.
196.6M
-27.45%		182.3M
-7.27%		148.5M
-18.54%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
MGLN ebit by date.MGLN ebit by date.
63.9M
-58.85%		50.8M
-20.50%		29.8M
-41.34%		N/AN/AN/AN/AN/A
Operating Margin
MGLN operating margin by date.MGLN operating margin by date.
1.29%1.11%0.65%N/AN/AN/AN/AN/A
EPS
YoY % growth
MGLN eps by date.MGLN eps by date.
2.41
-56.34%		3.73
54.77%		1.69
-54.69%		1.88
11.05%		3.48
85.33%		4.28
23.17%		6.48
51.22%		9.99
54.25%

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 21 Q1 / 22 Q2 / 22 Q3 / 22 Q4 / 22
EPS
Q2Q % growth		0.39
202.00%		1.13
-14.87%		0.70
535.18%		0.83
2,671.00%		0.63
63.16%
Revenue
Q2Q % growth		1.293B
9.10%		1.289B
10.97%		1.336B
9.46%		1.381B
10.08%		1.423B
10.07%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/AN/AN/A

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MGLN Yearly Revenue VS EstimatesMGLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B
MGLN Yearly EPS VS EstimatesMGLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
36.35%
EPS Next 5 Year
42.68%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
8.38%
Revenue Next 5 Year
7.97%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

MAGELLAN HEALTH INC / MGLN Forecast FAQ

What do analysts expect the price target to be for MAGELLAN HEALTH INC (MGLN)?

6 analysts have analysed MGLN and the average price target is 96.9 null. This implies a price increase of 2.01% is expected in the next year compared to the current price of 94.99.

Can you provide the upcoming earnings date for MAGELLAN HEALTH INC?

MAGELLAN HEALTH INC (MGLN) will report earnings on 2022-03-04, after the market close.

What are the consensus estimates for MGLN stock next earnings?

The consensus EPS estimate for the next earnings of MAGELLAN HEALTH INC (MGLN) is 0.39 null and the consensus revenue estimate is 1.29B null.

How many analysts cover MAGELLAN HEALTH INC (MGLN) stock?

The number of analysts covering MAGELLAN HEALTH INC (MGLN) is 6.